Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-041255
Filing Date
2014-06-13
Accepted
2014-06-13 15:29:32
Documents
1
Period of Report
2014-06-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6227
  Complete submission text file 0001209191-14-041255.txt   7538
Mailing Address 3501-C TRICENTER BLVD DURHAM NC 27713
Business Address 3501-C TRICENTER BLVD DURHAM NC 27713 919-544-8600
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE EMBRACADERO CTR STE 2700 SAN FRANCISCO CA 94111
Business Address
HANHAM ANN (Reporting) CIK: 0001286338 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 14909986